Providers Recognize R1 for Unwavering Commitment to Launching Innovative TechnologyCHICAGO, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...
NuvemRx, a leading tech-enabled pharmacy solutions company for community health providers, today announced it has acquired ...
R1 RCM expects the Ascension ransomware attack to drag down its revenue by between $75 million and $95 million in 2024, primarily because of a delay in timing of revenue from the second half of 2024 ...
MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial ...
Update 4:30pm: Updates shares, adds comment from R1 RCM holder. R1 RCM (NASDAQ:RCM) jumped 25% after New Mountain offered to buy the company for $13.75 a share in a cash. New Mountain also requested ...
MURRAY, Utah, Dec. 06, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of ...
(Reuters) -R1 RCM said on Thursday private-equity firms TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R) would acquire the healthcare technology company in a deal that values it at $8.9 ...
R1 RCM has received a noncompliance notice from Nasdaq’s Listing Qualifications Department resulting from R1’s delay in filing its quarterly report on Form 10-Q for the third quarter of 2023. Nasdaq’s ...
Leerink Partners analyst Michael Cherny reiterated a Buy rating on R1 RCM (RCM – Research Report) on March 7 and set a price target of $17.00. Michael Cherny has given his Buy rating due to a ...
Craig Hettenbach, an analyst from Morgan Stanley, reiterated the Buy rating on R1 RCM (RCM – Research Report). The associated price target remains the same with $17.00. Craig Hettenbach has given his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results